Menu Close

Member Company Listing

Member Company Listing

Corporate Membership of the Association for Clinical Data Management was recently launched. For a fixed annual subscription the corporate membership allows you to obtain the following benefits:

  • recognition as a Member Company of the ACDM
  • unlimited number of individual ACDM members at a single location of your organisation
  • add/remove members using our online Membership Management Area
  • reduced prices for attending training courses and the Annual Conference
  • free online listing of your organisation on the ACDM website
  • free, unlimited job postings

Join as an ACDM Member Company by clicking here

Please find below a listing of some of the Company Members of the ACDM

Filter by:

CROs | IT/Software | Pharma | Biotech | RecruitmentAcademic/Healthcare Provider

Amgen Ltd Amgen Ltd

Type: Pharma

Read More

Amgen has more than 500 staff in the UK and Ireland, working in both the commercial and research & development organisations. The UK and Ireland commercial team operates out of our Cambridge and Dublin offices.

Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each and every one of us.

Web: http://www.amgen.co.uk

AstraZeneca AstraZeneca

Type: Pharma

Read More

At AstraZeneca we have transformed our pipeline and returned to growth and, as a result of continued pipeline delivery and commercial execution, we are now entering a new stage of our journey. This is focused on enhanced innovation and the delivery of life-changing medicines that that contribute value to patients and society.
The fundamentals of our strategy are clear. We focus on innovative science and leadership in our three main therapy areas: Oncology; Cardiovascular, Renal and Metabolism; and Respiratory diseases. Backed by a global presence, with strength in Emerging Markets, particularly China, we have a portfolio of specialty and primary care medicines.
At the same time, the world around us is changing and the burden of disease is increasing. We are responding by increasing our focus on growth through innovation – being more patient-centric, doing more with technology, digital and data, and advancing more cutting-edge science.

Web: https://www.astrazeneca.com/

Services: Data Management, Statistics, Medical Writing, Monitoring, Project Management, Regulatory

Eisai Eisai

Type: Pharma

Read More

Eisai is one of the world’s leading research-based pharmaceutical companies. We define our corporate mission as “giving first thought to patients and their families, and to increasing the benefits health care provides,” which we call human health care (hhc). With operations in the U.S., Asia, Europe and it’s domestic home market of Japan, Eisai employs more than 11,000 people worldwide

Web: http://www.eisai.co.uk

Gilead Sciences Europe Ltd Gilead Sciences Europe Ltd

Type: Pharma

Read More

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead’s portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

Web: http://www.gilead.com

GlaxoSmithkline GlaxoSmithkline

Type: Pharma

Read More

Our Pharmaceutical business has a broad portfolio of innovative and established medicines. We currently focus on developing new medicines in respiratory and HIV/infectious diseases, oncology and immuno-inflammation; with discovery research exploring these and other areas

Web: http://www.gsk.com

GSK Vaccines GSK Vaccines

Type: Pharma

Read More

Our Vaccines business has a portfolio of more than 40 vaccines for every stage of life, helping to protect people against 22 diseases. We have a pipeline of 14 candidate vaccines in development. One third of our vaccines in development target diseases particularly prevalent in the developing world, including all three WHO infectious disease priorities: HIV, malaria and TB. Our other vaccines in development include vaccines for the treatment of COPD and prevention of Respiratory Syncytial Virus (RSV). In October 2017, our shingles vaccine, Shingrix, received regulatory approval in Canada and the US

Web: http://www.gsk.com

hVivo hVivo

Type: Pharma

Read More

hVIVO, a specialty biopharma company with clinical testing capabilities, is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases.

hVIVO changed its name from Retroscreen Virology in April 2015

Web: http://hvivo.com

Seqirus Seqirus

Type: Pharma

Read More

In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second largest influenza vaccine company in the world. Cutting-edge facilities, technologies and technical expertise, Seqirus will be a reliable supplier of seasonal influenza vaccine with the ability to rapidly respond to pandemic threats

Web: http://www.seqirus.com